Fonte: Pediatric Blood and Cancer. Nome do evento: Congress of the International Society of Paediatric Oncology. Unidade: FMRP
Assuntos: NEOPLASIAS CEREBRAIS, RADIOTERAPIA, QUIMIOTERAPIA
ABNT
BARONI, M. et al. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 09 jul. 2024. , 2015APA
Baroni, M., Fedatto, P., Andrade, A., Suazo, V., Queiróz, R., Tone, L. G., & Scrideli, C. A. (2015). Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Baroni M, Fedatto P, Andrade A, Suazo V, Queiróz R, Tone LG, Scrideli CA. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. 2015 ; 62 S283.[citado 2024 jul. 09 ]Vancouver
Baroni M, Fedatto P, Andrade A, Suazo V, Queiróz R, Tone LG, Scrideli CA. Silencig of GDF15 gene and response to radiotherapy and the treatment with temozolomide in glioblastoma cell lines. Pediatric Blood and Cancer. 2015 ; 62 S283.[citado 2024 jul. 09 ]